Putin, Merkel discuss possible joint vaccine production

0:00
play article
Subscribers can listen to this article
Both use the adenovirus vectors, although it remains unclear when these tests will go ahead.
Both use the adenovirus vectors, although it remains unclear when these tests will go ahead.
Pool/Getty Images
  • Russian President Vladimir Putin and German Chancellor Angela Merkel discussed the possibility of jointly producing coronavirus vaccines.
  • Both Russia and Germany have recently started mass vaccination drives at home to curb the spread of the coronavirus and avoid reimposing  lockdowns.
  • According to the Kremlin, "An agreement was reached to 'continue contacts on the issue' between the two countries' health ministries and specialised agencies."


Russian President Vladimir Putin and German Chancellor Angela Merkel discussed the possibility of jointly producing coronavirus vaccines in a phone call, the Kremlin said Tuesday.

"Issues of cooperation in combating the coronavirus pandemic were discussed with an emphasis on the possible prospects for joint production of vaccines," the Kremlin said in a statement.

The Kremlin added that an agreement was reached to "continue contacts on the issue" between the two countries' health ministries and specialised agencies.

The two leaders also discussed the settlement of the conflict between Kiev and pro-Russian separatist forces in eastern Ukraine, that has largely remained at a standstill since peace accords were signed in 2015.

Both Russia and Germany have recently started mass vaccination drives at home to curb the spread of the coronavirus and avoid reimposing nationwide lockdowns.

While Germany is using the vaccine jointly developed by Pfizer and the Mainz-based company BioNtech, Russia has put into mass circulation its homemade jab - Sputnik V.

Russia announced the registration of Sputnik - named after the Soviet-era satellite - in August, before the start of large-scale clinical trials, raising concerns over the fast-tracked procedure.

Some critics have described it as a tool to bolster Russia's geopolitical influence.

Russia started a mass vaccination drive in early December, making the jab first available to high-risk groups including medics, teachers and the elderly.

Alexander Gintsburg, the director of the state-run Gamaleya research centre that developed Sputnik, on Tuesday said that over 1 million people in Russia have received the jab so far.

Moscow also sent batches of its vaccine to Belarus, Serbia and Argentina and announced that 2.6 million doses will be supplied to Bolivia but acknowledged that it was struggling with production capacity.

In another sign of recognition for the Sputnik jab that has been viewed with scepticism by the West, British-Swedish drugmaker AstraZeneca in December announced a clinical trial programme that would use a combination of its vaccine and the Russian one.

Both use the adenovirus vectors, although it remains unclear when these tests will go ahead.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
ZAR/USD
14.54
(+0.08)
ZAR/GBP
20.50
(+0.17)
ZAR/EUR
17.65
(+0.15)
ZAR/AUD
11.54
(-0.32)
ZAR/JPY
0.14
(+0.65)
Gold
1798.34
(-0.40)
Silver
27.72
(+0.30)
Platinum
1253.00
(+0.44)
Brent Crude
64.18
(+0.19)
Palladium
2423.56
(+3.99)
All Share
66200.76
(+0.42)
Top 40
60747.41
(+0.42)
Financial 15
12354.99
(+0.99)
Industrial 25
86550.38
(-0.10)
Resource 10
66735.02
(+0.89)
All JSE data delayed by at least 15 minutes morningstar logo
Company Snapshot
Voting Booth
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, and I've gotten it.
21% - 1003 votes
No, I did not.
52% - 2506 votes
My landlord refused
28% - 1341 votes
Vote